Evidence map›Paper›PMID 39525019›Full record

ArticleTranslational cancer research2024

LncRNA

Tao Chen, Qiusheng Jiang, Zhenlin Wang, Fang Wang, Zan Fu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tao ChenDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-8071-4959
Qiusheng JiangDepartment of General Surgery, Nanjing Pukou People's Hospital, Nanjing, China.
Zhenlin WangDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Fang WangDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zan FuDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0003-4753-1821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) is one of the most common malignant tumors in the digestive system with a high incidence, a poor prognosis and an unsatisfactory therapeutic effect. Long non-coding RNAs (lncRNAs) play crucial roles in various biological processes related to tumor progression. Immune-related lncRNA gene Methods: This study collected data from The Cancer Genome Atlas (TCGA) database and explored the role of Results: In our study, high expression of Conclusions: LncRNA

Indexed as

AF117829.1colorectal cancer (CRC)immune microenvironmentimmunotherapyLong non-coding RNA (lncRNA)

Identifiers

PMID39525019
PMCPMC11543043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.